SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-18-009571
Filing Date
2018-04-27
Accepted
2018-04-27 16:05:49
Documents
5
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A sbph-defa14a_20180618.htm DEFA14A 45120
2 GRAPHIC g2018042714184102122450.jpg GRAPHIC 54210
3 GRAPHIC g2018042714184109922453.jpg GRAPHIC 14468
4 GRAPHIC g2018042714184107222452.jpg GRAPHIC 25495
5 GRAPHIC g2018042714184104622451.jpg GRAPHIC 89605
  Complete submission text file 0001564590-18-009571.txt   299754
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37718 | Film No.: 18783841
SIC: 2834 Pharmaceutical Preparations